About Neuro-Sys
Neuro-Sys is a company based in Gardanne (France) founded in 2013 by Yann Jaudouin and Lucie Mottier.. Neuro-Sys offers products and services including Preclinical Models, In Vitro Platform, and In Vivo Platform. Neuro-Sys operates in a competitive market with competitors including Wave Neuro, Cerca Insights, Afraxis, Nemosia and Rhenovia Pharma, among others.
- Headquarter Gardanne, France
- Founders Yann Jaudouin, Lucie Mottier
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neuro-Sys Sas
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$23.63 K (USD), Grant
Mar 01, 2017
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuro-Sys
Neuro-Sys offers a comprehensive portfolio of products and services, including Preclinical Models, In Vitro Platform, and In Vivo Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services for drug discovery in neurodegenerative diseases using in vivo models
Platform for in vitro studies of neuronal plasticity and disease mechanisms
Platform for animal-based testing in CNS and PNS disorders
Unlock access to complete
Unlock access to complete
Funding Insights of Neuro-Sys
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $23,625
-
First Round
First Round
(01 Mar 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Grant - Neuro-Sys | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neuro-Sys
Neuro-Sys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neuro-Sys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neuro-Sys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neuro-Sys Comparisons
Competitors of Neuro-Sys
Neuro-Sys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wave Neuro, Cerca Insights, Afraxis, Nemosia and Rhenovia Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Preclinical services to neurological science are provided.
|
|
| domain | founded_year | HQ Location |
Provides preclinical services in behavioral pharmacology for research and development.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive CNS pharmaceutical screening technologies for pre-clinical evaluations.
|
|
| domain | founded_year | HQ Location |
Preclinical services for neurological disorders are provided.
|
|
| domain | founded_year | HQ Location |
Biosimulation technology is provided for CNS drug discovery and development.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Neuro-Sys
When was Neuro-Sys founded?
Neuro-Sys was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Neuro-Sys located?
Neuro-Sys is headquartered in Gardanne, France. It is registered at Gardanne, Bouches-du-rhone, France.
Who is the current CEO of Neuro-Sys?
Yann Jaudouin is the current CEO of Neuro-Sys. They have also founded this company.
What does Neuro-Sys do?
Neuro-Sys was founded in 2013 in Gardanne, France, as a preclinical contract research organization focused on the biotechnology sector. Primary cell cultures are provided for drug effect studies in CNS conditions such as Alzheimers, Parkinsons, Huntingtons, multiple sclerosis, peripheral neuropathies, and ALS. Blood-brain-barrier models are also supplied to assess drug penetration. Compounds from medicinal plants are identified and developed for neurodegenerative applications, alongside pharmacological and clinical services for nutraceutical projects.
Who are the top competitors of Neuro-Sys?
Neuro-Sys's top competitors include Brains On-Line, Rhenovia Pharma and Brain Trust Bio.
What products or services does Neuro-Sys offer?
Neuro-Sys offers Preclinical Models, In Vitro Platform, and In Vivo Platform.
Who are Neuro-Sys's investors?
Neuro-Sys has 1 investor. Key investors include European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.